Environmental risk assessments for medicinal products containing, or consisting of, genetically modified organisms (GMOs)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/473191/06 - Corr
Effective from01/07/2007
KeywordsGenetically modified organism (GMO), environmental risk assessment (ERA)
DescriptionThis document explains the application of the centralised procedure to marketing authorisation (MA) applications for medicinal products consisiting of or containing genetically modified organisms. It outlines both the procedural issues affecting applications for MA for these products and the information related to the environmental risk assessment which should be included in the applications.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

In operation: 01/07/2007–present

Published: 01/12/2006

Published: 20/01/2005

Superseded documentAdopted guidelineIn operation: 01/01/1995–01/07/2007

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more